the aid library

LIST OPTIONS

Filter

7734

Информирование о рисках и взаимодействие с населением при отслеживании контактов больных COVID-19

World Health Organization WHO (2021) C_WHO

Contact tracing is a key element of WHO’s recommended approach to control the spread of COVID-19 by breaking the chains of human-to-human transmission. This document provides guidance to health authorities at all levels to improve the success rate of contact tracing by informing efforts with RCCE... more

Download (462)

View PDF (693)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (406)

View PDF (511)

Manual for case management of cutaneous leishmaniasis in the WHO Eastern Mediterranean Region

World Health Organization WHO WHO Regional Office for the Eastern Mediterranean (2014) CC

This publication represents a key step forward in translating Control of the leishmaniases (WHO Technical Report Series, No. 949) into a more practical tool for health personnel directly involved in the case management of cutaneous leishmaniasis. With this manual, countries will have, for the first ... more

Download (594)

View PDF (539)

Portable digital radiography system: technical specifications

World Health Organization WHO (2021) C_WHO

The portable diagnostic imaging technology covered by this document will serve not only the pressing demands for tuberculosis screening and triage but also other diseases. Therefore, the requirements, accessories, hardware and software packages listed in the following specifications are described in... more

Download (1295)

View PDF (1648)

WHO Operational package for assessing, monitoring and evaluating country pharmaceutical situations

WHO World Health Organization (2007) C_WHO

Guide for coordinators and data collectors - The WHO Operational Package for Assessing, Monitoring and Evaluating Country Pharmaceutical Situations is intended as a useful tool for researchers, policy-makers, planners and others who need to use standardized measurement tools to gather data and other... more

Download (1363)

View PDF (4308)

Psychological first aid: Facilitator’s manual for orienting field workers
recommended

Leslie Snider, Alison Schafer, Mark van Ommeren et al. World Health Organization WHO (2013) C_WHO

This manual is designed to orient helpers to offer psychologicalfirst aid (PFA) to people following a serious crisis event. PFA involves humane, supportive and practical assistance for people who are distressed, in ways that respect their dignity, culture and abilities. PFA is an approach that can b... more

External Link

CoroncareLife

Catholic Health Association of India CHAI; Billion Lives; Sisters Doctor Forum of India, et al. (2020) CC

In order to assist those who are undergoing stress because of Corona Virus crisis, an online Help Desk was launched at Catholic Health Association of India, Directorate, Hyderabad on 26th February. Billion Lives, a social impact tech company based in Bangalore, India, headed by Mr. John Santhosh,... more

Download (206)

View PDF (144)

الوقاية من األمراض غير السارية ومكافحتها: المبادئ التوجيهية للرعاية الصحية األولية في ظروف شح الموارد

World Health Organization (WHO) World Health Organization (WHO) (2023) C_WHO

The document, titled "Prevention and Control of Noncommunicable Diseases: Guidelines for Primary Health Care in Low-Resource Settings," provides the World Health Organization's (WHO) recommendations for managing noncommunicable diseases (NCDs) such as cancer, heart disease, diabetes, and chronic res... more

Download (1895)

View PDF (5561)

Clinical Management of Acute Diarrhoea

World Health Organization; UNICEF (2004) C_WHO

Available in Englisch, French, Spanish and Chinese The document provides guidelines for the management of acute diarrhoea, highlighting improved oral rehydration solutions (ORS) with reduced osmolarity and zinc supplementation. It emphasizes their effectiveness in reducing the duration and severity... more

Download (252)

View PDF (270)

Профилактика инфекций и инфекционный контроль в медицинских учреждениях, обеспечивающих реагирование на COVID-19: модуль из комплекса инструментов для оценки способности служб здравоохранения к реагир
recommended

World Health Organization WHO (2020) C_WHO

A module from the suite of health service capacity assessments in the context of the COVID-19 pandemic, Interim Guidance 20 October 2020. This self-assessment tool is designed for acute health-care facilities (i.e. tertiary and secondary) but can be modified for the use in long-term care facilities... more

Download (262)

View PDF (245)

Risk communication and community engagement for COVID-19 contact tracing: interim guidance

World Health Organization WHO (2021) C_WHO

Download (436)

View PDF (387)

Infection prevention and control in-service education and training curriculum

World Health Organisation (WHO) (2024) C_WHO

The primary objective of this curriculum is to equip health and care workers with the essential knowledge and competencies necessary for delivering safe and effective care. By doing so it aims to significantly reduce HAIs and combat antimicrobial resistance, thereby safeguarding both patient and HCW... more

Download (290)

View PDF (261)

Mask use in the context of COVID-19 (Arab Version)
recommended

World Health Organization (WHO) (2020) C_WHO

interim Guidance 1 December 2020. Updated version This document provides updated guidance on mask use in health care and community settings, and during home care for COVID-19 cases. It is intended for policy makers, public health and infection prevention and control professionals, health care manag... more

Download (264)

View PDF (240)

Expanding the Single-Visit Approach for Cervical Cancer Prevention: Successes and Lessons From Burkina Faso

Ouedraogo Y., Furlane G., Fruhauf T. et al. Global Health: Science and Practice (2018) CC

Background: Cervical cancer accounts for 23% of cancer incidence and 22% of cancer mortality among women in Burkina Faso. These proportions are more than 2 and 5 times higher than those of developed countries, respectively. Before 2010, cervical cancer prevention (CECAP) services in Burkina Faso wer...e limited to temporary screening campaigns. Program Description: Between September 2010 and August 2014, program implementers collaborated with the Ministry of Health and professional associations to implement a CECAP program focused on coupling visual inspection with acetic acid (VIA) for screening with same-day cryotherapy treatment for eligible women in 14 facilities. Women with larger lesions or lesions suspect for cancer were referred for loop electrosurgical excision procedure (LEEP). The program trained providers, raised awareness through demand generation activities, and strengthened monitoring capacity. Methods: Data on program activities, service provision, and programmatic lessons were analyzed. Three data collection tools, an individual client form, a client registry, and a monthly summary sheet, were used to track 3 key CECAP service indicators: number of women screened using VIA, proportion of women who screened VIA positive, and proportion of women screening VIA positive who received same-day cryotherapy. Results: Over 4 years, the program screened 13,999 women for cervical cancer using VIA; 8.9% screened positive; and 65.9% received cryotherapy in a single visit. The proportion receiving cryotherapy on the same day started at a high of 82% to 93% when services were provided free of charge, but dropped to 51% when a user fee of $10 was applied to cover the cost of supplies. After reducing the fee to $4 in November 2012, the proportion increased again to 78%. Implementation challenges included difficulties tracking referred patients, stock-outs of key supplies, difficulties with machine maintenance, and prohibitive user fees. Providers were trained to independently monitor services, identify gaps, and take corrective actions. Conclusions: Following dissemination of the results that demonstrated the acceptability and feasibility of the CECAP program, the Burkina Faso Ministry of Health included CECAP services in its minimum service delivery package in 2016. Essential components for such programs include provider training on VIA, cryotherapy, and LEEP; provider and patient demand generation; local equipment maintenance; consistent supply stocks; referral system for LEEP; non-prohibitive fees; and a monitoring data collection system. more

External Link (1081)

哮喘重要事实 - Asthma - Key Facts 2024

World Health Organization WHO (2024) C_WHO

Asthma is a chronic lung disease affecting people of all ages. It is caused by inflammation and muscle tightening around the airways, which makes it harder to breathe. Symptoms can include coughing, wheezing, shortness of breath and chest tightness. These symptoms can be mild or severe and can co... more

Download (174)

View PDF (982)

Asma -Datos y cifras 2024

World Health Organization WHO (2024) C_WHO

Download (167)

View PDF (883)

Астма - Основные факты 2024

World Health Organization WHO (2024) C_WHO

Asthma is a chronic lung disease affecting people of all ages. It is caused by inflammation and muscle tightening around the airways, which makes it harder to breathe.Symptoms can include coughing, wheezing, shortness of breath and chest tightness. These symptoms can be mild or severe and can come a... more

External Link

IARC Learning Platform

International Agency for Research on Cancer World Health Organisation (WHO) (2024) C_WHO

Website last accessed on 20.03.2024 The IARC Learning portal provides a single access point to a wide variety of learning and training resources, organized into different learning platforms that are developed and maintained in collaboration with IARC research groups and key collaborators. The t... more

Download (163)

View PDF (392)

Asthme - Principaux faits 2024

World Health Organization WHO (2024) C_WHO

Download (251)

View PDF (257)

WHO implementation tool for pre-exposure prophylaxis of HIV infection - Module 3

World Health Organization (WHO) World Health Organization (WHO) (2017) C_WHO

Module 3 Counsellors July 2017 Module 3: Counsellors. This module is for staff who counsel people as they consider PrEP or start taking PrEP and support them in coping with side-effects and adherence strategies. Those who counsel PrEP users may be lay, peer or professional counsellors and hea... more

Psychological first aid: Facilitator’s manual for orienting field workers recommended

Mask use in the context of COVID-19 (Arab Version) recommended

Psychological first aid: Facilitator’s manual for orienting field workers
recommended

Mask use in the context of COVID-19 (Arab Version)
recommended